Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 500-110-3 | CAS number: 50586-59-9 1 - 6.5 moles ethoxylated
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- short-term repeated dose toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: guideline GLP study
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 009
- Report date:
- 2009
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 009
- Report date:
- 2009
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 407 (Repeated Dose 28-Day Oral Toxicity Study in Rodents)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.7 (Repeated Dose (28 Days) Toxicity (Oral))
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- Propylidynetrimethanol, ethoxylated
- EC Number:
- 500-110-3
- EC Name:
- Propylidynetrimethanol, ethoxylated
- Cas Number:
- 50586-59-9
- Molecular formula:
- C3H5(CH2O(C2H4O)nH) sum of n: >1 - <6.5 mol EO
- IUPAC Name:
- Propylidynetrimethanol, ethoxylated
- Details on test material:
- - Name of test material (as cited in study report): Lupranol VP 9236
- Purity: 99.9 g/100 g
- Physical state: liquid (viscous)/colorless, clearThe analysis demonstrated the stability of the test substance in the vehicle (drinking water) up to 4 hours at room temperature. In conclusion the test substance preparations were made daily prior to the administration and therefore the stability was verified.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- - Amount of vehicle (if gavage): 5 ml/kg bw
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- For the present study no appropriate analytical method was found to monitor the stability of Lupranol VP 9236 in drinking water. Therefore further analyses were necessary after the finalization of the report. An additionally stability analysis was carried out at the low dose level administered in
this 28 day repeated toxicity study (1g/100 ml). This analysis demonstrated the stability of the test substance in the vehicle (drinking water) up to 4 hours at room temperature. In conclusion the test substance preparations were made daily prior to the administration and therefore the stability was verified. - Duration of treatment / exposure:
- 28 days
- Frequency of treatment:
- once daily
Doses / concentrations
- Remarks:
- Doses / Concentrations:
100, 300 and 1000 mg/kg bw
Basis:
actual ingested
- No. of animals per sex per dose:
- five
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection : By request of the sponsor
- Positive control:
- no positive control
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: daily
DETAILED CLINICAL OBSERVATIONS: Yes (incl. Open Field Observations (OFO))
- Time schedule: weekly
BODY WEIGHT: Yes
- Time schedule for examinations: weekly
FOOD CONSUMPTION: YES
- Time schedule for examinations: weekly
FOOD EFFICIENCY:
- Body weight gain in kg/food consumption in kg per unit time X 100 calculated as time-weighted averages from the consumption and body weight gain data: Yes
WATER CONSUMPTION: Yes
- Time schedule for examinations: weekly
OPHTHALMOSCOPIC EXAMINATION: Yes
HAEMATOLOGY: Yes
- Time schedule for collection of blood: once, day 29
- How many animals: all dose groups incl. controls
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: once, day 29
- How many animals: all dose groups incl. controls
URINALYSIS: Yes
NEUROBEHAVIOURAL EXAMINATION: Yes
- Time schedule for examinations: FOB: once, day 26; MA: once, day 27
- Dose groups that were examined: all dose groups incl. controls
- Battery of functions tested: Functional Observational Battery (FOB); Motor Activity (MA) - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes (all dose groups and controls)
ORGAN Weights:
Adrenals, brain, epididymides, heart, kidneys, Liver, Ovaries, Spleen, Testes, Thymus, uterus, Thyriod glands
Fixed organs:
All gross lesions; Salivary glands (mandibular and sublingual glands); Esophagus; Stomach (forestomach and glandular stomach); Duodenum, jejunum and ileum; Cecum, colon and rectum; Liver; Pancreas; Brain; Pituitary gland; Sciatic nerve; Spinal cord (cervical, thoracic and lumbar cords); Eyes; Adrenal glands; Thyroid glands; Parathyroid glands; Trachea; Lungs; Pharynx; Larynx; Nose (nasal cavity); Aorta; Heart; Bone marrow (femur); Lymph nodes (mesenteric and axillary lymph nodes); Spleen; Thymus; Kidneys; Urinary bladder; Testes; Ovaries; Oviducts, uterus and vagina; Epididymides, prostate and seminal vesicle;. Female mammary gland; Skin; Skeletal muscle; Sternum with marrow; Femur with knee joint; Extraorbital lacrimal glands
HISTOPATHOLOGY: Yes (high dose group and controls)
- Microscopic:
The hematoxylin-eosin stained slides of the following organs were assessed by light-microscopy for the control and high dose group animals.
all gross lesions, Adrenal glands; Aorta; Bone marrow (femur); Brain; Cecum, colon and rectum; Duodenum (with Peyer’s patches); Esophagus; Eyes with optic nerve; Female mammary gland; Heart; Kidneys; Liver; Lungs; Lymph nodes (mesenteric and axillary lymph nodes); Ovaries; Oviducts, uterus and vagina; Pancreas; Parathyroid glands; Pituitary gland; Prostate, seminal vesicle and epididymides; Salivary glands mandibular and sublingual glands); Sciatic nerve; Skin; Spinal cord (cervical, thoracic and lumbar cords); Spleen; Stomach (forestomach and glandular stomach); Testes; Thymus; Thyroid glands; Trachea; Urinary bladder.
Organs embedded in paraplast for the low and mid dose animals of the following organs: For all gross lesions and the liver
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Food efficiency:
- no effects observed
- Water consumption and compound intake (if drinking water study):
- no effects observed
- Ophthalmological findings:
- no effects observed
- Haematological findings:
- no effects observed
- Clinical biochemistry findings:
- effects observed, treatment-related
- Urinalysis findings:
- no effects observed
- Behaviour (functional findings):
- no effects observed
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- no effects observed
- Details on results:
-
OPHTHALMOSCOPIC EXAMINATION:
The observed corneal stipplings and remainders of the papillary membrane were equally distributed between the dosed animals and the controls as well as were without any doseresponse relationship. Therefore, these findings were clearly not related to treatment and without any toxicological relevance.
HAEMATOLOGY
Concerning hematology parameter values no treatment-related, adverse effects were measured. In the male rats of the 1000 mg/kg bw/d dose group the platelet counts were decreased compared to the controls. This change was the only one concerning hematology and hemostaseology parameters. Additionally, the median of the platelet counts was within the historical control range (724 – 999 G/L). Therefore, this deviation was regarded as incidental and not adverse.
CLINICAL CHEMISTRY
In the male rats of the 300 and 1000 mg/kg bw/d dose groups the cholesterol levels were increased compared to the controls. This increase was dose-dependent and slightly above the historical control range (1.45 – 1.89 mmol/L). However, this was the only parameter in clinical chemistry which was deviated in these animals and therefore it is regarded as nonadverse, although it cannot be excluded that this change was treatment-related.
NEUROBEHAVIOUR
Motor Activity: Regarding the overall motor activity, no substance-related findings were observed. Comparing the single intervals with the control groups, motor activity was significantly increased in males of group 3 and group 1 at interval 11. This single occurrence was without any significant influence on the overall motor activity and therefore assessed as not toxicologically relevant.
FOB: Deviations from "zero values" were obtained in several animals. However, as most findings were equally distributed between treated groups and controls, were without a doseresponse relationship or occurred in single animals only, these observations were considered to have been incidental.
ORGAN WEIGHTS
Absolute Weights: Compared to controls (= 100%) only the kidney weights of 100 mg/kg (89%, p<0.05) and 300 mg/kg (89%, p<0.05) dose group females revealed a statistical significant weight decrease and the thymus of 100 mg/kg (121%, p<0.05) females showed a statistically significant weight increase. These variations are considered incidental and not related to treatment due to missing dose-response relationship.
All other mean absolute weight parameters did not show relevant differences compared to the control group.
Relative Weights: Compared to controls (= 100%) only the thymus weights of 100 mg/kg (122%, p<0.05) dose group females revealed a statistical significant weight increase. This variation is considered incidental and not related to treatment due to missing dose-response relationship.
All other mean relative weight parameters did not show relevant differences compared to the control group.
Effect levels
- Dose descriptor:
- NOAEL
- Effect level:
- >= 1 000 mg/kg bw/day (actual dose received)
- Sex:
- male/female
- Basis for effect level:
- other: Regarding clinical examinations, clinical pathology as well as pathology the limit dose of 1000 mg/kg bw did not cause any signs of toxicity
Target system / organ toxicity
- Critical effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- The NOAEL for the given test substance was 1000 mg/kg bw/day.
- Executive summary:
In a repeated dose oral toxicity study in rats (Wistar, OECD TG 407), the test substance was administered via gavage to 5 rats/sex/dose at 0, 100, 300, 1000 mg/kg bw for 4 weeks. Regarding clinical examination, clinical pathology, the oral administration by gavage up to and including the limit dose of 1000 mg/kg bw and day over a period of 4 weeks did not cause any signs of toxicity. Based on these results the NOAEL was considered to be 1000 mg/kg bw/day in both sexes.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.